22 May 2013
Keywords: hgs, repifermin, starts, phase, iib, ulcers, human
Article | 09 April 2001
Human Genome Sciences has started a Phase IIb trial of repifermin, alsoknown as keratinocyte growth factor-2, in patients with chronic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.